Aligos Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary: Aligos Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2019 to Q3 2024.
Aligos Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $300K, unchanged year-over-year.
Aligos Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.29M, a 23.6% decline year-over-year.
Aligos Therapeutics, Inc. annual Depreciation for 2023 was $1.56M, a 32.4% decline from 2022.
Aligos Therapeutics, Inc. annual Depreciation for 2022 was $2.31M, a 23.6% decline from 2021.
Aligos Therapeutics, Inc. annual Depreciation for 2021 was $3.02M, a 10.4% increase from 2020.

Depreciation, Trailing 12 Months (USD)

Depreciation, Quarterly (USD)

Depreciation, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$1.29M	$300K	$0	0%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-06
Q2 2024	$1.29M	$300K	-$100K	-25%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-06
Q1 2024	$1.39M	$282K	-$172K	-37.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$1.56M	$405K	-$125K	-23.6%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-12
Q3 2023	$1.68M	$300K	-$200K	-40%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-06
Q2 2023	$1.88M	$400K	-$200K	-33.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-06
Q1 2023	$2.08M	$454K	-$222K	-32.8%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-07
Q4 2022	$2.31M	$530K	-$148K	-21.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-12
Q3 2022	$2.45M	$500K	-$300K	-37.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-02
Q2 2022	$2.75M	$600K	-$200K	-25%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	$2.95M	$676K	-$65K	-8.77%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-04
Q4 2021	$3.02M	$678K	-$338K	-33.3%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	$3.36M	$800K	+$92K	+13%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-02
Q2 2021	$3.27M	$800K	+$120K	+17.6%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	$3.15M	$741K	+$410K	+124%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-04
Q4 2020	$2.74M	$1.02M			Oct 1, 2020	Dec 31, 2020	10-K	2022-03-10
Q3 2020		$708K	+$321K	+82.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020		$680K			Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020		$331K			Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-10
Q3 2019		$387K			Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-25

* An asterisk sign (*) next to the value indicates that the value is likely invalid.